Starlite Components Ltd
BSE:517548
Starlite Components Ltd
BSE:517548
Price:
3.64
INR
Market Closed
Market Cap:
₹182k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Starlite Components Ltd
BSE:517548
|
IN |
|
Toyo Sugar Refining Co Ltd
TSE:2107
|
JP |
|
Gakken Holdings Co Ltd
TSE:9470
|
JP |
|
A
|
Allergy Therapeutics PLC
OTC:AGYTF
|
UK |
|
I
|
Insecticides (India) Ltd
NSE:INSECTICID
|
IN |
Balance Sheet
Balance Sheet Decomposition
Starlite Components Ltd
Starlite Components Ltd
Balance Sheet Decomposition is not available for
Starlite Components Ltd
Starlite Components Ltd
Balance Sheet
Starlite Components Ltd
Starlite Components Ltd
Currency: INR
| Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash & Cash Equivalents |
0
|
1
|
0
|
2
|
2
|
2
|
2
|
2
|
2
|
5
|
3
|
3
|
|
| Cash |
0
|
1
|
0
|
2
|
2
|
2
|
2
|
2
|
2
|
3
|
2
|
3
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
2
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
120
|
119
|
156
|
196
|
599
|
204
|
50
|
33
|
33
|
17
|
16
|
18
|
|
| Accounts Receivables |
120
|
119
|
156
|
196
|
552
|
172
|
37
|
20
|
19
|
2
|
3
|
5
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
47
|
32
|
13
|
13
|
14
|
14
|
13
|
12
|
|
| Inventory |
103
|
157
|
186
|
265
|
264
|
127
|
12
|
5
|
4
|
2
|
0
|
0
|
|
| Other Current Assets |
57
|
65
|
76
|
64
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
280
|
341
|
419
|
526
|
867
|
334
|
64
|
40
|
39
|
23
|
19
|
20
|
|
| PP&E Net |
43
|
54
|
56
|
58
|
79
|
72
|
45
|
40
|
34
|
29
|
4
|
3
|
|
| Intangible Assets |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
11
|
9
|
0
|
7
|
76
|
76
|
11
|
36
|
36
|
36
|
0
|
0
|
|
| Long-Term Investments |
3
|
10
|
9
|
9
|
12
|
10
|
1
|
0
|
0
|
0
|
0
|
2
|
|
| Other Long-Term Assets |
9
|
11
|
8
|
0
|
8
|
6
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Total Assets |
347
N/A
|
425
+22%
|
497
+17%
|
601
+21%
|
1 043
+74%
|
499
-52%
|
121
-76%
|
117
-4%
|
110
-6%
|
90
-18%
|
23
-74%
|
26
+14%
|
|
| Liabilities | |||||||||||||
| Accounts Payable |
194
|
47
|
83
|
173
|
513
|
95
|
16
|
25
|
27
|
14
|
3
|
10
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
2
|
0
|
0
|
35
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
161
|
19
|
6
|
6
|
141
|
9
|
8
|
8
|
8
|
8
|
7
|
5
|
|
| Total Current Liabilities |
355
|
66
|
91
|
179
|
654
|
139
|
24
|
33
|
34
|
22
|
10
|
15
|
|
| Long-Term Debt |
81
|
79
|
47
|
47
|
14
|
19
|
49
|
48
|
48
|
48
|
16
|
16
|
|
| Deferred Income Tax |
0
|
0
|
0
|
6
|
10
|
11
|
11
|
11
|
10
|
9
|
0
|
0
|
|
| Other Liabilities |
3
|
322
|
326
|
316
|
301
|
257
|
119
|
119
|
119
|
119
|
1
|
0
|
|
| Total Liabilities |
440
N/A
|
467
+6%
|
465
-1%
|
548
+18%
|
980
+79%
|
426
-57%
|
203
-52%
|
210
+4%
|
211
+1%
|
198
-6%
|
27
-86%
|
31
+14%
|
|
| Equity | |||||||||||||
| Common Stock |
68
|
108
|
171
|
171
|
171
|
171
|
171
|
171
|
171
|
171
|
171
|
171
|
|
| Retained Earnings |
161
|
151
|
139
|
118
|
108
|
98
|
252
|
264
|
272
|
278
|
175
|
175
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
93
N/A
|
43
+54%
|
32
N/A
|
53
+63%
|
63
+19%
|
73
+16%
|
81
N/A
|
93
-15%
|
101
-8%
|
107
-6%
|
4
+96%
|
4
-14%
|
|
| Total Liabilities & Equity |
347
N/A
|
425
+22%
|
497
+17%
|
601
+21%
|
1 043
+74%
|
499
-52%
|
121
-76%
|
117
-4%
|
110
-6%
|
90
-18%
|
23
-74%
|
26
+14%
|
|
| Shares Outstanding | |||||||||||||
| Common Shares Outstanding |
5
|
9
|
17
|
17
|
17
|
17
|
17
|
17
|
17
|
17
|
17
|
17
|
|
Switch to:
Switch to:
See Also
Discover More
